Current Mesothelioma News
When it comes to mesothelioma, statistical accuracy is essential to making sure that the proper resources are allocated for prevention, treatment, and more. That’s why there is a rising level of concern over what is happening with Quebec’s health ministry: in response to a newspaper inquiry, they released numbers on mesothelioma incidence for the first time in 7 years, and the numbers that they provided are very much in question. read more
When 83-year-old Joan Morris of Essex in the United Kingdom was diagnosed with malignant mesothelioma, her family was both devastated and confused. The rare and fatal form of cancer is cause by exposure to asbestos, and they were not aware of any such exposure she might have had in her life. The illness moved quickly: she began feeling ill in June of 2016, was diagnosed in November, and by March she was gone. Now the family is seeking justice, trying to determine whether her death was a result of years of washing asbestos from her first husband’s work clothing in the years between the mid-1960s and 1970s. read more
While the general population is aware that asbestos is bad, and may even assume that it was banned long ago in the United States, those whose lives have been affected by malignant mesothelioma know all-too well that it is still in use and in place in America’s industries and its infrastructure. With the passage of a law reforming and strengthening the Toxic Substances Control Act in 2016, health and environmental advocates had hoped that change was finally coming and that the substance’s use in the United States would soon come to an end, but the Trump administration has reversed course. In response, six Non-Governmental Organizations (NGOs) have adopted a new strategy: they have submitted a petition to the United States Environmental Protection Agency, requesting that currently existing exemptions to the way that asbestos is treated be dropped.
Mesothelioma researchers attending last week’s International Association for the Study of Lung Cancer (ASLC) 19th World Conference on Lung Cancer attended the gathering with high hopes for breakthroughs in fighting the challenging disease, and they did not leave disappointed. Among the most promising news that the group heard was of groundbreaking results achieved by Aldeyra Therapeutics, Inc. in a Phase 1/2 clinical trial of their drug ADX-1612 (ganetespib).
In the world of mesothelioma research, there are both unexpected victories and devastating disappointments, and sometimes those disparate results can occur while examining the same treatment protocol. An example of this was seen recently in the Lume-Meso study of a new medication, the kinase inhibitor nintedanib. Nintedanib had previously delivered highly promising results in a phase 2 trial that combined it with the standard mesothelioma chemotherapy treatment of pemetrexed/cisplatin. Unfortunately, a report delivered during the International Association for the Study of Lung Cancer’s 19th World Conference on Lung Cancer revealed that once the study had moved on to the protocols involving a larger group of participants, the previous results were contradicted, with scientists involved finding that the combination of medications provided none of the survival benefit that had previously been seen.
When Shana Maurer learned that the apartment where she lived and worked had been contaminated with asbestos and the landlord had done nothing to warn residents, one of her first thoughts was of malignant mesothelioma and other asbestos-related diseases. Now the young woman has filed a class-action lawsuit against Commons at Sylvan Highlands, accusing them of failure to disclose that the luxury apartment units contained a significant health hazard.
Residents and former employees alike are voicing mesothelioma concerns after a lawsuit has accused a Portland property management of covering up their mismanagement of in-place asbestos in a building under renovation. The lawsuit has been filed by two former employees, who are charging Tandem Property Management with conspiracy and wrongful termination: they are seeking $40 million in damages. read more
Over the years, Americans have come to understand that profit-motivated asbestos manufacturers chose to put millions of people at risk for malignant mesothelioma. As victims have come forward and sought justice they have been awarded multi-million dollar verdicts by juries intent on sending a message to corporations, warning them not to put human health at risk again. Despite the strength of this lesson, many companies have continued to take chances with our health, failing to guard against lethal contaminations and shoddy quality practices: now there is a question as to whether supplement manufacturers selling “healthy” products are among them.